Given that IL-17 plays a key role in both psoriasis and liver disease, it is important to determine how persistent inflammation in both organs (liver and skin) can promote, in psoriatic patients, a more rapid progression to steatohepatitis or cirrhosis, or even to hepatocellular carcinoma. Here, IL17A is linked to psoriasis.